Aquestive Therapeutics (AQST) Reiterated at Market Outperform by Citizens

May 15, 2026 4:50 AM

Citizens analyst Jason Butler reiterated a Market Outperform rating and $10.00 price target on Aquestive Therapeutics (NASDAQ: AQST).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found